The Alliance for Regenerative Medicine (ARM) published a report about ATMPs market access in key European countries. It provides a comprehensive review of the regulatory and market access framework across key European countries and identifies potential hurdles.
This report is available as a PDF to download or view online. A brief summary of the report is also available here.
